Transcatheter pulmonary valvulation: Current indications and available devices

Archives of Cardiovascular Diseases

Volumn 107, Issue 11, 2014, Pages 625-634

  Hascoët, Sebastien ^a,b,c   Acar, Philippe ^a,b   Boudjemline, Younes ^a,d,e  

^a Groupe de Cathétérisme Interventionnel Pédiatrique et Congénital   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c Université de Toulouse   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Congenital heart diseases; Edwards sapien ; Melody ; Pulmonary valve; Pulmonic valve; Transcatheter pulmonary valve; Transcatheter pulmonary valve replacement

Indexed keywords

ARTERY COMPRESSION; ARTICLE; BACTERIAL ENDOCARDITIS; BALLOON CATHETER; BLEEDING; BLOOD VESSEL INJURY; CONGENITAL HEART DISEASE; GUIDE WIRE; GUIDING CATHETER; HEART VALVE DELIVERY CATHETER; HEMATOMA; HUMAN; LUNG EDEMA; LUNG INJURY; OPEN HEART SURGERY; PERCUTANEOUS AORTIC VALVE; PRACTICE GUIDELINE; PULMONARY VALVE PROSTHESIS; PULMONARY VALVED CONDUIT; RIGHT VENTRICLE TO PULMONARY ARTERY CONDUIT; STENT; STENT FRACTURE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT INDICATION; ADVERSE EFFECTS; BIOPROSTHESIS; DEVICES; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; PATHOPHYSIOLOGY; PROCEDURES; PROSTHESIS; PROSTHESIS FAILURE; PULMONARY VALVE; PULMONARY VALVE INSUFFICIENCY; PULMONARY VALVE STENOSIS; STANDARDS; TREATMENT OUTCOME;

BIOPROSTHESIS; CARDIAC CATHETERIZATION; HEART DEFECTS, CONGENITAL; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; PULMONARY VALVE; PULMONARY VALVE INSUFFICIENCY; PULMONARY VALVE STENOSIS; TREATMENT OUTCOME;

EID: 84928036491     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2014.07.048     Document Type: Review

References (64)

1. Rubio-Alvarez V, Limon R, Soni J. [Intracardiac valvulotomy bymeans of a catheter]. Arch Inst Cardiol Mex 1953;23:183-92.
2. Kirklin JW, Dushane JW, Patrick RT, Donald DE, Hetzel PS, Harshbarger HG, et al. Intracardiac surgery with the aid of a mechanical pump-oxygenator system (gibbon type): report of eight cases. Proc Staff Meet Mayo Clin 1955;30:201-6.
3. Davies H. Catheter mounted valve for temporary relief of aortic insufficiency. Lancet 1965;285:250.
4. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992;13:704-8.
5. Pavcnik D, Wright KC, Wallace S. Development and initial experimental evaluation of a prosthetic aortic valve for transcatheter placement. Work in progress. Radiology 1992;183:151-4.
6. Bonhoeffer P, Boudjemline Y, Saliba Z, Hausse AO, Aggoun Y, Bonnet D, et al. Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation 2000;102:813-6.
7. Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, et al. Percutaneous replacement of pulmonary valve in a right ventricle to pulmonary artery prosthetic conduit with valve dysfunction. Lancet 2000;356:1403-5.
8. Eicken A, Ewert P, Hager A, Peters B, Fratz S, KuehneT, et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J2011;32:1260-5.
9. Boudjemline Y, Brugada G, Van-Aerschot I, Patel M, Basquin A, Bonnet C, et al. Outcomes and safety of transcatheter pulmonary valve replacement in patients with large patched right ventricular outflow tracts. Arch Cardiovasc Dis 2012;105:404-13.
10. Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB. Implantation of the Melody® transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the U.S. clinical trial. J Am Coll Cardiol 2009;54:1722-9.
11. McElhinney DB, Hellenbrand WE, Zahn EM, Jones TK,Cheatham JP, Lock JE, et al. Short- and medium-term out-comes after transcatheter pulmonary valve placement in the expanded multicenter U.S. Melody® valve trial. Circulation 2010;122:507-16.
12. McElhinney DB, Cheatham JP, Jones TK, Lock JE, Vincent JA, Zahn EM, et al. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the U.S. Melody® valve trial. Circ Cardiovasc Interv 2011;4:602-14.
13. Lurz P, Coats L, Khambadkone S, Nordmeyer J, BoudjemlineY, Schievano S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation 2008;117:1964-72.
14. Lindsey CW, Parks WJ, Kogon BE, Sallee 3rd D, Mahle WT. Pulmonary valve replacement after tetralogy of Fallot repair in preadolescent patients. Ann Thorac Surg 2010;89:147-51.
15. Momenah TS, El Oakley R, Al Najashi K, Khoshhal S, Al Qethamy H, Bonhoeffer P. Extended application of percutaneous pulmonary valve implantation. J Am Coll Cardiol 2009;53:1859-63.
16. Khambadkone S, Coats L, Taylor A, Boudjemline Y, Derrick G, Tsang V, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation 2005;112:1189-97.
17. Berman DP, McElhinney DB, Vincent JA, Hellenbrand WE, Zahn EM. Feasibility and short-term outcomes of percutaneous transcatheter pulmonary valve replacement in small (< 30 kg) children with dysfunctional right ventricular outflow tract conduits. Circ Cardiovasc Interv 2014;7:142-8.
18. Butera G, Milanesi O, Spadoni I, Piazza L, Donti A, Ricci C, et al. Melody® transcatheter pulmonary valve implantation. Results from the registry of the Italian Society of Pediatric Cardiology. Catheter Cardiovasc Interv 2013;81:310-6.
19. Vezmar M, Chaturvedi R, Lee KJ, Almeida C, Manlhiot C, McCrindle BW, et al. Percutaneous pulmonary valve implantation in the young 2-year follow-up. JACC Cardiovasc Interv 2010;3:439-48.
20. Garay F, Webb J, Hijazi ZM. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: first report in a human patient. Catheter Cardiovasc Interv 2006;67:659-62.
21. Ewert P, Horlick E, Berger F. First implantation of the CE-marked transcatheter SAPIEN® pulmonic valve in Europe. Clin Res Cardiol 2011;100:85-7.
22. Haas NA, Moysich A, Neudorf U, Mortezaeian H, Abdel-Wahab M, Schneider H, et al. Percutaneous implantation of the Edwards SAPIEN® pulmonic valve: initial results in the first 22 patients. Clin Res Cardiol 2013;102:119-28.
23. Boone RH, Webb JG, Horlick E, Benson L, Cao QL, Nadeem N,et al. Transcatheter pulmonary valve implantation using the Edwards SAPIEN® transcatheter heart valve. Catheter Cardiovasc Interv 2010;75:286-94.
24. Kenny D, Hijazi ZM, Kar S, Rhodes J, Mullen M, Makkar R, et al. Percutaneous implantation of the Edwards SAPIEN®transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol 2011;58:2248-56.
25. Shimazaki Y, Blackstone EH, Kirklin JW. The natural history of isolated congenital pulmonary valve incompetence: surgical implications. Thorac Cardiovasc Surg 1984;32:257-9.
26. Zahka KG, Horneffer PJ, Rowe SA, Neill CA, Manolio TA, Kidd L, et al. Long-term valvular function after total repair of tetralogy of Fallot. Relation to ventricular arrhythmias. Circulation 1988;78:III14-9.
27. Abd El Rahman MY, Abdul-Khaliq H, Vogel M, Alexi-Meskishvili V, Gutberlet M, Lange PE. Relation between right ventricular enlargement, QRS duration, and right ventricular function inpatients with tetralogy of Fallot and pulmonary regurgitation after surgical repair. Heart 2000;84:416-20.
28. Carvalho JS, Shinebourne EA, Busst C, Rigby ML, Redington AN. Exercise capacity after complete repair of tetralogy of Fallot: deleterious effects of residual pulmonary regurgitation. Br Heart J 1992;67:470-3.
29. Hayes CJ, Gersony WM, Driscoll DJ, Keane JF, Kidd L, O'Fallon WM, et al. Second natural history study of congenital heart defects. Results of treatment of patients with pulmonary valvar stenosis. Circulation 1993;87:I28-37.
30. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000;356:975-81.
31. Harrison DA, Harris L, Siu SC, MacLoghlin CJ, Connelly MS, Webb GD, et al. Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot. J Am Coll Cardiol 1997;30:1368-73.
32. Van Straten A, Vliegen HW, Hazekamp MG, Bax JJ, Schoof PH, Ottenkamp J, et al. Right ventricular function after pulmonary valve replacement in patients with tetralogy of Fallot. Radiology 2004;233:824-9.
33. Coats L, Khambadkone S, Derrick G, Sridharan S, Schievano S, Mist B, et al. Physiological and clinical consequences of relief of right ventricular outflow tract obstruction late after repair of congenital heart defects. Circulation 2006;113:2037-44.
34. Eyskens B, Reybrouck T, Bogaert J, Dymarkowsky S, Daenen W, Dumoulin M, et al. Homograft insertion for pulmonary regurgitation after repair of tetralogy of fallot improves cardiorespiratory exercise performance. Am J Cardiol 2000;85:221-5.
35. Bove EL, Kavey RE, Byrum CJ, Sondheimer HM, Blackman MS, Thomas FD. Improved right ventricular function following late pulmonary valve replacement for residual pulmonary insufficiency or stenosis. J Thorac Cardiovasc Surg 1985;90:50-5.
36. Therrien J, Siu SC, Harris L, Dore A, Niwa K, Janousek J, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 2001;103:2489-94.
37. Stark J, Bull C, Stajevic M, Jothi M, Elliott M, de Leval M. Fate of subpulmonary homograft conduits: determinants of late homograft failure. J Thorac Cardiovasc Surg 1998;115:506-14 [discussion 514-516].
38. Peng LF, McElhinney DB, Nugent AW, Powell AJ, Marshall AC, Bacha EA, et al. Endovascular stenting of obstructed right ventricle to pulmonary artery conduits: a 15-year experience. Circulation 2006;113:2598-605.
39. Mallula KK, Kenny D, Hijazi ZM. Transjugular Melody® valve placement in a small child with protein losing enteropathy. Catheter Cardiovasc Interv 2014, http://dx.doi.org/10.1002/ccd.25487 [Epub ahead of print].
40. Lurz P, Giardini A, Taylor AM, Nordmeyer J, Muthurangu V, Odendaal D, et al. Effect of altering pathologic right ventricular loading conditions by percutaneous pulmonary valve implantation on exercise capacity. Am J Cardiol 2010;105:721-6.
41. Lurz P, Puranik R, Nordmeyer J, Muthurangu V, Hansen MS, Schievano S, et al. Improvement in left ventricular filling properties after relief of right ventricle to pulmonary artery conduit obstruction: contribution of septal motion and interventricular mechanical delay. Eur Heart J 2009;30:2266-74.
42. Lurz P, Nordmeyer J, Giardini A, Khambadkone S, Muthurangu V, Schievano S, et al. Early versus late functional outcome after successful percutaneous pulmonary valve implantation: are the acute effects of altered right ventricular loading all we can expect? J Am Coll Cardiol 2011;57:724-31.
43. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Dean-field JE, Galie N, et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010;31:2915-57.
44. Ministère des affaires sociales et de la santé. Décision du 20 mars 2012 de l'Union nationale des caisses d'assurance maladie relative à la liste des actes et prestations pris en chargepar l'assurance maladie. Journal Officiel de la République Française 2012, texte 8.
45. Feltes TF, Bacha E, Beekman 3rd RH, Cheatham JP, Feinstein JA, Gomes AS, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation 2011;123:2607-52.
46. McElhinney DB, Hennesen JT. The Melody® valve and Ensemble® delivery system for transcatheter pulmonary valve replacement. Ann N Y Acad Sci 2013;1291:77-85.
47. Fiszer R, Szkutnik M, Hijazi ZM, Bialkowski J. Transcatheter implantation of Edwards SAPIEN® THV valve in pulmonary position. Kardiol Pol 2011;69:749-50.
48. Guccione P, Milanesi O, Hijazi ZM, Pongiglione G. Transcatheter pulmonary valve implantation in native pulmonary outflow tract using the Edwards SAPIEN® transcatheter heart valve. Eur J Cardiothorac Surg 2012;41:1192-4.
49. Khambadkone S. Percutaneous pulmonary valve implantation. Ann Pediatr Cardiol 2012;5:53-60.
50. Faza N, Kenny D, Kavinsky C, Amin Z, Heitschmidt M, Hijazi Z. Single center comparative outcomes of the Edwards SAPIEN® and medtronic Melody® transcatheter heart valves in the pulmonary position. Catheter Cardiovasc Interv 2013;82(4):E535-41, http://dx.doi.org/10.1002/ccd.24680 [Epub 2013 Mar 18].
51. Alsulami G, Patel M, Malekzadeh-Milani S, Bonnet D, Boudjem-line Y. Hyperacute flash pulmonary oedema after transcatheter pulmonary valve implantation: the Melody® of an overwhelmed left ventricle. Arch Cardiovasc Dis 2014;107(4):219-24, http://dx.doi.org/10.1016/j.acvd.2014.03.007 [Epub 2014May 2].
52. Patel M, Iserin L, Bonnet D, Boudjemline Y. Atypical malignant late infective endocarditis of Melody® valve. J Thorac Cardiovasc Surg 2012;143:e32-5.
53. McElhinney DB, Benson LN, Eicken A, Kreutzer J, Padera RF, Zahn EM. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody® valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv 2013;6:292-300.
54. Nordmeyer J, Khambadkone S, Coats L, Schievano S, Lurz P, Parenzan G, et al. Risk stratification, systematic classification, and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation. Circulation 2007;115:1392-7.
55. Glockler M, Halbfabeta J, Koch A, Achenbach S, Dittrich S. Multimodality 3D-roadmap for cardiovascular interventions in congenital heart disease: a single-center, retrospective analysis of 78 cases. Catheter Cardiovasc Interv 2013;82:436-42.
56. Biermann D, Schonebeck J, Rebel M, Weil J, Dodge-Khatami A. Left coronary artery occlusion after percutaneous pulmonary valve implantation. Ann Thorac Surg 2012;94:e7-9.
57. Mauri L, Frigiola A, Butera G. Emergency surgery for extrinsic coronary compression after percutaneous pulmonary valve implantation. Cardiol Young 2013;23(3):463-5, http://dx.doi.org/10.1017/S1047951112001187 [Epub 2012 Nov 26].
58. Morray BH, McElhinney DB, Cheatham JP, Zahn EM, Berman DP, Sullivan PM, et al. Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience. Circ Cardiovasc Interv 2013;6:535-42.
59. Fraisse A, Assaidi A, Mauri L, Malekzadeh-Milani S, Thambo JB, Bonnet D, et al. Coronary artery compression during intention to treat right ventricle outflow with percutaneous pulmonary valve implantation: incidence, diagnosis, and outcome. Catheter Cardiovasc Interv 2014;83:E260-8.
60. Nordmeyer J, Coats L, Lurz P, Lee TY, Derrick G, Rees P, et al. Percutaneous pulmonary valve-in-valve implantation: a successful treatment concept for early device failure. Eur Heart J 2008;29:810-5.
61. Nordmeyer J, Lurz P, Khambadkone S, Schievano S, Jones A, McElhinney DB, et al. Pre-stenting with a bare metal stent before percutaneous pulmonary valve implantation: acute and 1-year outcomes. Heart 2011;97:118-23.
62. Lee C, Kim YM, Lee CH, Kwak JG, Park CS, Song JY, et al. Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction: implications for optimal timing of pulmonary valve replacement. J Am Coll Cardiol 2012;60:1005-14.
63. Therrien J, Provost Y, Merchant N, Williams W, Colman J,Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 2005;95:779-82.
64. Tweddell JS, Simpson P, Li SH, Dunham-Ingle J, Bartz PJ, Earing MG, et al. Timing and technique of pulmonary valve replacement in the patient with tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2012;15:27-33.